Canada>Canada http://www.africanseer.com/ganabolnet-190a.pdf gms-supplements.de  A separate Phase III trial, testing ramucirumab in advanced gastric cancer, met its main goal by extending patients' overall survival. It was the second stomach cancer trial that showed the drug improved survival. The company said it will provide detailed data from that study some time next year.